戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 scular risk factors, and dietary composition were collected at 0, 3, 6, and 12 months.
2                                        Blood was collected at 1, 4, 12, 24, 36, and 48 weeks.
3 ek from day 12 to 1 mo of age, and specimens were collected at 1 and 5 mo of age.
4                    Tissue biopsies and blood were collected at 1 to 2, 6 to 8, 24, and 48 hours post-
5 ng growth, graft outcomes and adverse events were collected at 1 year (113 patients) and 2 years (106
6 e was administered yearly, and blood samples were collected at 1, 2, 3, 5, 6, 7, 10, and 13 years of
7    Transepidermal water loss (TEWL) measures were collected at 12 months from a subset (n=150) of the
8 PDF data for nanocrystalline platinum (n-Pt) were collected at 12.5 GPa with a single 5 s X-ray expos
9                         Data on maternal BMI was collected at 15 weeks of gestation, and paternal BMI
10         Anterior and posterior planar images were collected at 15 min, 1.5 h, 4 h, and 8 h.
11                                      Samples were collected at 15 sites along the four streams.
12  and nutritional and environmental exposures were collected at 15 weeks' gestation, birth, and 2, 6,
13                 Milk samples from 25 mothers were collected at 2 wk, 4 mo, and 9 mo postpartum for th
14 V13 at ages 2, 4, 6, and 12 months; NP swabs were collected at 2, 4, 6, 7, 12, 13, 18, and 24 months,
15                                    Fractions were collected at 20 min intervals (2 muL) before and af
16                        Atrial tissue samples were collected at 21 days for histological and molecular
17 on participant schooling and smoking history were collected at 23-25 y of age.
18                              Blood and liver were collected at 24 hours after ischemia-reperfusion fo
19 s from schools in Melbourne, Australia, data were collected at 3 assessments between 2004 and 2012.
20                  Clinical signs and symptoms were collected at 3 time points from hospitalized infant
21 es for functional limitations and disability were collected at 3, 6 and 12 months.
22                                Serum samples were collected at 3, 6, and 12 months after treatment in
23 amples from mice inoculated with RML scrapie were collected at 30, 60, 90, 105, and 120 days post ino
24                       Gastric mucosa samples were collected at 35, 50, or 80 weeks of age from mice t
25          In this study, water column samples were collected at 39 sites in the nGOM, 21 of which were
26                                        Blood was collected at 4, 8, and 16 years, and sensitization e
27 nscriptome following VEEV infection, samples were collected at 4, 8, and 16 h postinfection and RNA-S
28                                Blood samples were collected at 4, 8, and 16 years of age for analysis
29                               Spleen samples were collected at 40 days post injection (dpi), and sequ
30                    Fecal samples (n = 3,108) were collected at 50 field sites, tested for species and
31                                        Urine was collected at 6, 12, and 18 weeks.
32                                Blood samples were collected at 6 time points.
33                                      Tissues were collected at 7, 11, 29, and 67 days after infusion,
34                                Serum samples were collected at 7, 14 and 21 day post infection (DPI)
35       Having partnered with seven OPOs, data were collected at 70 hospitals with high donor potential
36 unction, airway inflammation, and remodeling were collected at 72 h after injection or after 2 weeks
37                      Mother and infant blood was collected at 8 wk postpartum.
38                      Fouled membrane samples were collected at 8 h, and 1, 2, and 4 weeks on a lab-sc
39                               Samples of DNA were collected at 9 sites from different countries.
40     Subsequently, nanoliter eluate fractions are collected at a rate of one fraction per second on a
41 ately categorize cluster residency when data are collected at a site distant from households.
42     This will enable a much larger sample to be collected at a fraction of the cost, facilitating fut
43  or 640 nm), and the maximal emission signal was collected at a shorter wavelength (i.e., higher ener
44         In the TRACK-TBI Pilot study, plasma was collected at a single time point from 196 patients w
45             Food and environmental specimens were collected at a hospital (hospital A) where 6 patien
46 rains found in clinical fecal specimens that were collected at a single hospital over an 18-year time
47  G1/G3/G4-P[8]-I1-C1-R1-A1-N1-T1-E1-H1) that were collected at a single location in Washington, DC, d
48             In this study, tree-core samples were collected at a Superfund site to determine if the s
49                                         Data were collected at a wastewater treatment plant (WWTP) in
50 e, DeltaP, tidal volume, Cdyn, and PaO2/FIO2 were collected at acute respiratory distress syndrome on
51                                        Blood was collected at admission and plasma CD133 and CD39 MP
52                 Serum and blood cell samples were collected at admission.
53  microbiological, and echocardiographic data were collected at admission.
54                                Fecal samples were collected at age 1 week, 1 month, and 1 year, and h
55 th, and 1 year, and hypopharyngeal aspirates were collected at age 1 week, 1 month, and 3 months and
56                                Fecal samples were collected at age 3 to 16 months, and the children w
57                Intestinal microbiome samples were collected at age 3-6 months in children participati
58 sumed milk and serum samples of the children were collected at age 4 years.
59                                      Samples were collected at age 6 and 8 weeks of life.
60                                Blood samples were collected at ages 2, 4, 6, and 11 years, and serum-
61                                     MRI data were collected at ages 8 and 10.
62                         Mie scatter patterns are collected at all photodiode angles for each of the i
63 cal, and post-bronchodilator spirometry data were collected at an in-person study visit.
64                               Filter samples were collected at an urban background site in the city c
65 l blood mononuclear cells (PBMCs) and plasma were collected at and 2 time points after diagnosis.
66 ntional absorption optics, provided the data are collected at appropriate sample concentrations and t
67 tion was measured in spot-urine samples that were collected at approximately 12, 20, and 35 wk of ges
68 cluding Nematodirus), as well as body weight were collected at approximately 16, 20 and 24 weeks of a
69  early life and 12 adults (>/=18 years old), were collected at autopsy in Jackson, Mississippi.
70            Between 5 and 12 metastatic sites were collected at autopsy together with available primar
71 elected case-mix factors were recommended to be collected at baseline to facilitate comparison of res
72 elected case-mix factors were recommended to be collected at baseline.
73                                        Blood was collected at baseline (visit 1) and 30 days after pr
74                                        Blood was collected at baseline and at 3 and 4 wk.
75                                        Blood was collected at baseline and at the midpoint and end of
76  Self-reported weight (previously validated) was collected at baseline and updated every 2 y during t
77                               Induced sputum was collected at baseline before rhinovirus inoculation
78  For each patient, a peripheral blood sample was collected at baseline for the evaluation of CTCs and
79 n lifestyle score components and confounders was collected at baseline.
80                             Plasma and urine were collected at baseline (in a subset), the beginning
81                       Liver biopsy specimens were collected at baseline (n = 48) and 48 weeks (n = 34
82                                         Data were collected at baseline (n=14 567) and after interven
83                                Blood samples were collected at baseline 2 h, 6 h and daily up to 10 d
84                              Laboratory data were collected at baseline and 1 mo after (90)Y radioemb
85                                Blood samples were collected at baseline and 16 weeks, and analyzed fo
86                                Fecal samples were collected at baseline and 16 weeks; bile acids were
87 urs after challenge, and bone marrow samples were collected at baseline and 24 hours after challenge
88 vironmental factors (SES and social network) were collected at baseline and 3-mo follow-up, together
89 nt-reported outcomes (PROs) and biospecimens were collected at baseline and 4 and 9 months after enro
90  Clinical and standardized radiographic data were collected at baseline and 6 months after treatment.
91                        Colonoscopic biopsies were collected at baseline and 6 months or when patients
92          Peripheral blood and sputum samples were collected at baseline and 7 and 24 hours after chal
93                                         Data were collected at baseline and 8 wk after therapy.
94          Diffusion imaging and clinical data were collected at baseline and after 1 year.
95                                Fecal samples were collected at baseline and after 4 weeks and analyze
96                        Fasting blood samples were collected at baseline and after 6 wk of the interve
97 l impression cytology and tear fluid samples were collected at baseline and after an 8-week treatment
98                            Duodenal biopsies were collected at baseline and after gluten challenge.
99                                     Measures were collected at baseline and after intervention by ass
100                                         Data were collected at baseline and after treatment (1 week a
101  child emotional and behavioral outcome data were collected at baseline and at 2, 6, and 12 months po
102                                Blood samples were collected at baseline and at an early time-point (2
103           Demographic and clinical variables were collected at baseline and at follow-up and analyzed
104  and gingival crevicular fluid (GCF) samples were collected at baseline and at follow-up visits.
105          Detailed data on clinical phenotype were collected at baseline and at regular clinic reviews
106                               Breath samples were collected at baseline and during isotopic plateaus.
107 , anthropometric measures, and blood samples were collected at baseline and endline.
108 tifocal visual evoked potential (mfVEP) data were collected at baseline and every 6 to 8 weeks until
109 ss data related to bundle element compliance were collected at baseline and monthly during the interv
110                Angina and QOL questionnaires were collected at baseline and months 1, 6, and 12.
111                                         Data were collected at baseline and prospectively every 2 mon
112  and average days on mechanical ventilation) were collected at baseline and quarterly during the inte
113 nal partnerships and self-management ability were collected at baseline and three months later.
114        In addition, samples of blood and GCF were collected at baseline and week 8.
115                              Ophthalmic data were collected at baseline and yearly visits by means of
116                                   HRQoL data were collected at baseline for 362 (88%) of 410 patients
117 heral blood mononuclear cells or whole blood were collected at baseline from 425 participants and fro
118                                         Data were collected at baseline from September 1, 2007, throu
119 onal magnetic resonance imaging (fMRI) scans were collected at baseline prior to treatment and at 3-m
120 ng smoking and body mass index measurements, were collected at baseline using questionnaires.
121                              Blood and stool were collected at baseline, 1, 3, 6 and 12 months.
122 etailed clinical data and sputum for culture were collected at baseline, 2 months, and 5-6 months.
123                                         Data were collected at baseline, 2 wks after the intervention
124                         Self-report measures were collected at baseline, 4 months, and 12 months.
125         The interviews from the parent study were collected at baseline, 6 months, and 12 months post
126                                         ECGs were collected at baseline, after reperfusion, and analy
127 P and 32 patients with GAgP, and GCF samples were collected at baseline, after the treatment, and dur
128                                Blood samples were collected at baseline, at 6 wk, and after the inter
129                                         Data were collected at baseline, before WM, and after WM (wee
130                                     Measures were collected at baseline, completion of the interventi
131                    Blood and nasal scrapings were collected at baseline, during reactions, and after
132                             Outcome measures were collected at baseline, each treatment session, post
133 aliva samples per day for 3 consecutive days were collected at baseline, end of treatment, and 1, 3,
134                Serum cytokine concentrations were collected at baseline, midpoint, and endpoint to as
135 mmunospot (IFN-gamma ELISPOT), blood samples were collected at baseline, post-doses 2, 3, and 4.
136                                         Data were collected at baseline, post-test (3 months after di
137 etric, body composition, and behavioral data were collected at baseline, postintervention (6 months),
138 graphics, clinical data, and health literacy were collected at baseline.
139               Blood and tumor tissue samples were collected at baseline.
140 osocial status, and clinical characteristics were collected at baseline.
141 plaque and gingival crevicular fluid samples were collected at baseline; after 7, 14, and 21 days of
142                                         Data were collected at: baseline, end of intervention and thr
143                           Cord blood samples were collected at birth and analyzed for 25(OH)D levels
144                                     Biopsies were collected at both endoscopies for PGE2 quantificati
145 em/Behavior Activation System questionnaire) were collected at both time points.
146 er biopsy samples from 43 HCV+ LT recipients were collected at clinical HCVrec time and at 3 years po
147 a on sociodemographics, feeding, and illness were collected at defined intervals.
148 inistered to tumor-bearing mice, and samples were collected at defined times during pulse and chase p
149 2008, a total of 671 marine sediment samples were collected at depths from 5 to 2012 m throughout the
150 dities, demographic characteristics, and QoL were collected at diagnosis and 12 and 24 mo after diagn
151                           Oral rinse samples were collected at diagnosis and after treatment (9, 12,
152                        Data on 1345 subjects were collected at diagnosis and at 28 days, 6, 12, and 2
153 etabolic profiling of plant leaves that have been collected at different time points during the growi
154 /kg, i.p. every 12 h) or saline-treated mice was collected at different time points and tested ex viv
155 -stage heart failure and tissue samples that were collected at different disease stages from desmogle
156            First, crystals of both compounds were collected at different electrodes under the influen
157                              Blood and urine were collected at different intervals and analysed by LC
158                                Slags samples were collected at different sites throughout various cit
159                              S. Daniele hams were collected at different stages during dry-curing and
160                                Colon tissues were collected at different time points during colitis d
161                                Liver tissues were collected at different timepoints during developmen
162 al, mid-jejunal effluents and plasma samples were collected at different times during 7h after meal i
163                                      Digesta were collected at different times, in the different comp
164                                Neonatal data were collected at discharge, and sociodemographic inform
165 r dosing, vaginal biopsy and luminal samples were collected at discrete locations in 8 subjects.
166 hroughout the study, and a spot urine sample was collected at each visit.At baseline, 8 participants
167 s for total and specific IgE of the children were collected at each follow-up visit.
168                                  Blood spots were collected at each observation and assayed for CRP l
169                                   Bloodspots were collected at each observation and assayed for CRP l
170                  At least 5 pairs of samples were collected at each of 7 time points (1 day, 3 days,
171             Counterregulatory hormone levels were collected at each of these glycemic levels and rCBF
172 hr black carbon, and 96-hr nitrogen dioxide) were collected at each school for 16 weeks.
173 oint was assessment of adverse events, which were collected at each visit and for 28 days after the l
174                           Adverse event data were collected at each visit and included an assessment
175                                      Samples were collected at eight time points to monitor rates and
176        Demographic and lifestyle information was collected at enrollment; disease, treatment, and out
177                                       Stools were collected at enrollment and, for cases, after a 5-m
178                                         Data were collected at enrollment, each trimester, birth, and
179             Data on development of infection were collected at evaluations performed at screening, ba
180                                       Plasma was collected at four time points: preoperative, postane
181                A total of 590 faecal samples were collected at four roosting sites in the USA and cul
182                 Placenta and umbilical blood were collected at GD 165.
183 , mid-IR emissivity image cubes of paintings were collected at high collection rates with a low-noise
184                               Number of nevi was collected at inclusion.
185 etes, alcohol abuse, HIV, or HBV coinfection were collected at inclusion.
186                                   TA muscles were collected at intervals over the 36 h of exercise re
187                                         Data were collected at kindergartens and parish centers by fa
188                               Plasma samples were collected at L1, L2, and 1 day after LT (postoperat
189 also more common in individuals for whom DNA was collected at least 1 year before diagnosis with leuk
190 ic, clinical, radiological, and genetic data were collected at Massachusetts General Hospital (Boston
191 imensional distributions in (99m)Tc activity were collected at millimeter-resolution using decay-corr
192                                    Specimens were collected at monthly interval (months 1-6 and month
193 ution is more difficult to defend if samples are collected at multiple locations in the farm-to-table
194                  In rat tissues, which could be collected at multiple time points after osteotomy, th
195                                        Blood was collected at multiple time points.
196 rse during initial and repeat KPro placement were collected at multiple centers across the country.
197                                The ONTT data were collected at multiple centers in the United States.
198 r stream reaches were evaluated, and samples were collected at multiple sites during summer and sprin
199                               Plasma samples were collected at multiple time points and used for the
200 lasma and peripheral blood mononuclear cells were collected at multiple time points, and comprehensiv
201                             Sediment samples were collected at nine sampling sites within Admiralty B
202                                  Information was collected at participants' homes through structured
203  The aerosol produced by the ultrasonic unit was collected at patient's chest area, doctor's chest ar
204                                      Samples were collected at patient enrollment and not during acut
205                       In this study, retinas were collected at postnatal (P) days P5-30, 90, 180, and
206  administrated to subjects and blood samples were collected at predetermined time points.
207                      Blood and urine samples were collected at predetermined times.
208 swab specimens, and/or whole stool specimens were collected at presentation, and serum was collected
209 eactive protein and faecal calprotectin will be collected at recruitment and 3 months, and patient ex
210 surements, blood samples, and lifestyle data were collected at recruitment.
211                      Blood samples and urine were collected at regular intervals to determine (68)Ga-
212  data including medical and family histories were collected at research laboratories at Boston Childr
213                                  Nasal swabs were collected at respiratory illness onset and every 7-
214              Blood and muscle biopsy samples were collected at rest and after exercise during primed
215                                     The data are collected at room temperature.
216                                Serum samples were collected at routine clinic visits from 50 pediatri
217                                Blood samples were collected at routine clinical appointment visits, c
218         Hereditary angioedema attack history was collected at screening.
219 riodontal parameters and unstimulated saliva were collected at screening, baseline, and each week dur
220                                        Blood was collected at selected time points.
221                     After DRB removal, cells are collected at several time points, and tagged RNA is
222        The data underlying this relationship were collected at sites with varying proportions of foli
223                                         Data were collected at specialist centers on patients diagnos
224 asma, echocardiograms, and clinical outcomes were collected at standardized intervals in breast cance
225                                    The cells were collected at stationary phase and examined by Raman
226             In Barcelona, samples of fine PM were collected at street level at sites with variable tr
227 ding demographic and clinical information to be collected at study enrollment, important aspects rela
228               BM aspirates and blood samples were collected at surgery, or in local anesthesia in non
229 ubcutaneous abdominal adipose tissue samples were collected at surgical intervention.
230              A verbal review of systems also was collected at that time.
231 induces particle movement, and the particles are collected at the surface of one of the two electrode
232                                The electrons are collected at the UME, and the current-versus-time da
233 between week 5 and the end of month 7, feces was collected at the ages of 5 weeks (n = 571), 13 weeks
234  climate dynamics available worldwide, which was collected at the Hubbard Brook Experimental Forest i
235                                       Plasma was collected at the time of bronchoscopy and analyzed f
236            A small amount of vitreous sample was collected at the time of explant.
237 we and 20 samples of goat colostrum and milk were collected at the 1st, 2nd, 3rd, 4th, 5th and 15th d
238                    Non-fasting blood samples were collected at the ages of 1, 1.5, 2, 3, and 4 years
239                                Blood samples were collected at the ages of 1, 2, 3, 5, 6, 7, 10, and
240                                         Data were collected at the annual Twins Days Festival in Twin
241                 Standardized spirometry data were collected at the baseline examination.
242                Their blood and urine samples were collected at the baseline, 1-, 3- and 6-months duri
243 uced gingivitis study, and gingival biopsies were collected at the baseline, induction, and resolutio
244 mains of a small bear (Protarctos abstrusus) were collected at the Beaver Pond fossil site in the Hig
245  vitamin B-12, and phospholipid fatty acids, were collected at the beginning and end of the feeding p
246 inidia chinensis) (Gold3, Gold9 and Hort16A) were collected at the commercial harvesting time, and ph
247       Data for this observational case study were collected at the Department of Ophthalmology, Unive
248                        Fasting blood samples were collected at the end of each intervention arm.
249                       Fasting plasma samples were collected at the end of each intervention diet.
250                        Fasting blood samples were collected at the end of each sodium intervention.
251 tion fine-structure (XAFS) spectra of Br-Ash were collected at the Hg L(III)-edge, Br K-edge and S K-
252 pective case series, 202 BAL fluid specimens were collected at the Johns Hopkins Hospital between Aug
253     The two samples (Coastal and Marine DOM) were collected at the mouth of the Ogeechee River and in
254                                   Drug costs were collected at the National Database of Health Prices
255  Organization guideline phases of the switch were collected at the national-level and in each of the
256 were receiving antiretroviral therapy (ART), were collected at the Nsambya Hospital in Kampala, Ugand
257 mation brine, and synthetic NaCl+CaCl2 brine were collected at the pressures from 100 to 200 bar, tem
258                    Home settled dust samples were collected at the same time points for quantificatio
259 others (n = 107) and their infants (n = 108) were collected at the same time points for the measureme
260 te, respiratory rate, and oxygen saturation) were collected at the same time points.
261 iscontinuation was more likely when cultures were collected at the start of therapy (adjusted OR 1.68
262                                Clinical data were collected at the time of diagnosis of ERM and at th
263 n Guidelines), and predefined risk variables were collected at the time of enrollment to enable progn
264              Pulmonary hemodynamic variables were collected at the time of PoPH diagnosis, at last ev
265                      Nasal wash (NW) samples were collected at the time of recruitment.
266 ction episodes, and postoperative medication were collected at the time of surgery and 1, 2, and 5 ye
267                                         Data were collected at the time of surgery and at 1, 2, and 5
268              Blood and sinus tissue explants were collected at the time of surgery from control subje
269                                Human samples were collected at the University of Utah between June 20
270                                        Crabs were collected at the wreck location and 4 nmi north and
271                                  Air samples were collected at the Zeppelin observatory in the remote
272  polymorphisms related to choline metabolism were collected at their first prenatal visit.
273 from the coronary sinus and the femoral vein were collected at those time points and then analyzed fo
274                         The air samples have been collected at three sites according to urban functio
275                                         Data was collected at three time points: (1) baseline (time 0
276                     Three 24-h sweat samples were collected at three different days from each subject
277              A total of 796 pharyngeal swabs were collected at three separate clinical centers.
278                              Aerosol samples were collected at three sites located in the Mediterrane
279 h aerodynamic diameters between 0.056-18 mum were collected at three sites: (i) an active smelter ope
280 hort of 29 pregnant women, from whom samples were collected at three time points during pregnancy and
281                                         Data were collected at three waves: baseline, 6 and 12 months
282 l, sociodemographic, and behavioral measures were collected at three- to six-month intervals from a b
283                                 Rectal swabs were collected at time of acute diarrhea and 14 days lat
284 house gas flux that results when corn stover is collected at two different rates from corn-soybean an
285                      Three indigenous fruits were collected at two conservation areas in Kanchanaburi
286                  Northern pike (Esox lucius) were collected at two locations in 2011 near Montreal Is
287                                 Measurements were collected at two locations, one directly over and t
288 nisotropy measures of white matter integrity were collected at two sites as a part of the Bipolar-Sch
289                                These fossils were collected at two sites in Germany, Neumark-Nord and
290                 Daily PM2.5 and PM10 samples were collected at two sites in Houston over a 2-week per
291        Ambient high volume PM2.5 air samples were collected at two sites in the Pacific Northwest: (1
292 four commercial cultivars from North America were collected at two sizes (3-5 and>7cm).
293 on was affected by weathering, field samples were collected at various intervals up to two years afte
294                              Liver specimens were collected at various timepoints after injection and
295 C-matched clonal T cells (G14D-CCV), and PBL were collected at various times after immunization for f
296 g omeprazole, twice daily) and fecal samples were collected at week 8.
297  and fine (PM2.5) particulate matter samples were collected at weekly intervals with both bacterial a
298 articipated in ACT-1 or ACT-2; efficacy data were collected at weeks 8, 30, and 54 (for ACT-1 only).
299      Recalled GWG and breastfeeding behavior were collected at years 7 and 10.
300                             Serum and livers were collected at zeitgeber time 2, 6, 10, 14, 18, and 2

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top